There are a host of reported clinical applications for CBD, many of which are for conditions that currently have no effective, or affordable, pharmacological solutions, and/or for which highly addictive opiates and other painkillers are the only known relief. In addition to shining a beacon of hope on treatment of painful or disruptive conditions like many autoimmune and nervous system disorders, CBD bears enormous value as a non-addictive pain relief therapy.
There is a significant body of scientific evidence detailed in academic and scientific publications, including the Journal of Neurophysiology, Molecular Pharmacology, Neuroscience and Nature, that shows that the human body is engineered to reap the benefits of CBD. The discovery of the endogenous cannabinoid system (ECS) in the 1980s revealed a network of receptors located throughout the body, in the brain, organs, connective tissues, glands, and immune cells. The purpose of these receptors is to achieve homeostasis, a biologic environment that remains stable no matter what external influences exert themselves. Cannabinoids, including CBDs, are made to attach to these receptors.
The absence of a blood-brain barrier in the ECS makes it physically impossible to overdose on cannabis, making its analgesic properties particularly valuable in light of a medical environment where prescription drug abuse for the treatment of pain has reached epidemic proportions.
The ECS can influence a variety of physiological processes including appetite, pain sensation, mood and memory, and in tempering cannabis’ psychoactive impact. Complementing this functionality, CBD has been shown to possess potent anti-tumoral, antioxidant, anti-spasmodic, anti-psychotic, anti-convulsive, and neuroprotective properties, in addition to the ability to fire serotonin receptors, causing an anti-depressant effect. Specifically, the International Cannabinoid Research Society (ICRS) has uncovered numerous molecular pathways through which CBD has great therapeutic potency. Metaphorically, the ECS system is made to process CBD (and other cannabinoids) and CBD’s healing powers are expressed through the ECS.
CBD (the red column), is Cannabinoid Creation’s sole and exclusive focus and yields 16 documented clinical benefits and no psychotropic effects; relief without the “high” or any spaciness or memory loss.
Pure CBD is insoluble in water and not readily absorbed into the bloodstream. However, when Nervoss’ nano CBD is converted into a water-soluble liquid, it quickly goes into the solution, forming cannabinoid emulsion droplets with enhanced bioavailiability. This results in a superior ingredient.
Nervoss uses high profile laboratories for producing and manufacturing CBD products. We are the global leader in manufacturing and producing nanotechnology. Nervoss’ nano CBD is a patent formula that uses optimized composition and a unique process to manufacture.
The size of Nervoss’ nano CBD particle is 10-500 nanometers. The minute size of Nervoss’ nano CBD leads to a much larger surface area of the hemp oil droplets. This leads to a much higher absorption rate in the bloodstream.
Nervoss’ nano CBD can also be used in a number of consumer products, including the cosmetic, pharmaceutical, food, and pet food industries. Due to their thermodynamic stability, Nervoss’ nano CBD do not lead to phase separation, thus enabling the formulation of stable high quality products.
